Literature DB >> 1480597

Antibody response in Plasmodium vinckei malaria after treatment with chloroquine and adjuvant interferon-gamma.

S Finnemann1, P G Kremsner, M F Chaves, C Schumacher, S Neifer, U Bienzle.   

Abstract

The antibody response of mice infected with Plasmodium vinckei after treatment with chloroquine either alone or in combination with interferon-gamma (IFN-gamma) was determined. Sequential serum samples were drawn from BALB/c mice receiving either 240 micrograms chloroquine on the day of infection or 120 micrograms chloroquine plus 10(4) units IFN-gamma daily for 11 days beginning on day 3 prior to infection. Mice treated with additional IFN-gamma showed an early induction of IgG2a response and a reduction in IgG1 antibodies as detected by the immunofluorescence technique at between 10 and 16 days after infection as compared with mice treated with chloroquine alone. Thus, IFN-gamma may partly exert its antimalarial activity via the induction of IgG2a antibody formation. At 4-6 weeks after infection, when mice from both groups resisted homologous re-infection, the predominant antibody isotypes found in both groups were IgG1 and IgG2a. Serum samples obtained from mice in both treatment groups at 6 weeks after infection were used for serum transfer experiments. When parasitised erythrocytes were preincubated with such immune serum, a retardation of the course of parasitaemia by 2 days was observed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1480597     DOI: 10.1007/bf00931511

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  26 in total

1.  Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens.

Authors:  M Troye-Blomberg; E M Riley; L Kabilan; M Holmberg; H Perlmann; U Andersson; C H Heusser; P Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

2.  Inhibition of Plasmodium vinckei-malaria in mice by recombinant murine interferon-gamma.

Authors:  U Bienzle; K G Fritsch; G Hoth; E Rozdzinski; K Köhler; M Kalinowski; P Kremsner; F Rosenkaimer; H Feldmeier
Journal:  Acta Trop       Date:  1988-09       Impact factor: 3.112

3.  Protective and pathological activity in serum of mice developing resistance to Plasmodium berghei infection.

Authors:  T P Schetters; J H Van Run van Breda; C Hermsen; J Curfs; W M Eling
Journal:  Parasite Immunol       Date:  1989-07       Impact factor: 2.280

4.  Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon.

Authors:  A Ferreira; L Schofield; V Enea; H Schellekens; P van der Meide; W E Collins; R S Nussenzweig; V Nussenzweig
Journal:  Science       Date:  1986-05-16       Impact factor: 47.728

5.  Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.

Authors:  I A Clark; N H Hunt; G A Butcher; W B Cowden
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

6.  Acquirement of protective immunity in mice through infection with an attenuated isolate and its failure in parent virulent Plasmodium berghei.

Authors:  S Waki; T Takagi; M Suzuki
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

7.  Conjugation of interferon-gamma to antigen enhances its adjuvanticity.

Authors:  A W Heath; J H Playfair
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

8.  Immune response in patients during and after Plasmodium falciparum infection.

Authors:  P G Kremsner; G M Zotter; H Feldmeier; W Graninger; R M Rocha; R Jansen-Rosseck; U Bienzle
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

9.  Antibody-independent immunity to reinfection malaria in B-cell-deficient mice.

Authors:  J L Grun; W P Weidanz
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.

Authors:  F D Finkelman; I M Katona; T R Mosmann; R L Coffman
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

View more
  4 in total

Review 1.  Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses.

Authors:  C E Taylor
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

2.  Reciprocal regulation of Th1- and Th2-cytokine-producing T cells during clearance of parasitemia in Plasmodium falciparum malaria.

Authors:  S Winkler; M Willheim; K Baier; D Schmid; A Aichelburg; W Graninger; P G Kremsner
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

3.  Cellular mechanisms in the immune response to malaria in Plasmodium vinckei-infected mice.

Authors:  H Perlmann; S Kumar; J M Vinetz; M Kullberg; L H Miller; P Perlmann
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

4.  In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB/c mice.

Authors:  Narges Nazifi; Mojtaba Tahmoorespur; Mohammad Hadi Sekhavati; Alireza Haghparast; Ali Mohammad Behroozikhah
Journal:  BMC Vet Res       Date:  2019-11-08       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.